molnupiravir
Showing 1 - 9 of 9
Influenza Infection Trial (Molnupiravir, Placebo molnupiravir, Placebo oseltamivir)
Not yet recruiting
- Influenza Infection
- Molnupiravir
- +4 more
- (no location specified)
Apr 5, 2023
Renal Impairment Trial in Miami, Tampa, Philadelphia (Molnupiravir)
Active, not recruiting
- Renal Impairment
- Molnupiravir
-
Hallandale Beach, Florida
- +3 more
Feb 2, 2023
Hepatic Impairment Trial in Hollywood, Miami, Philadelphia (Molnupiravir)
Completed
- Hepatic Impairment
- Molnupiravir
-
Hollywood, Florida
- +2 more
Jan 24, 2023
Respiratory Syncytial Virus Trial in London (Molnupiravir, Placebo, RSV A Memphis 37b)
Recruiting
- Respiratory Syncytial Virus
- Molnupiravir
- +2 more
-
London, London, City Of, United KingdomhVIVO Services ( Site 0001)
Feb 2, 2023
Viral Infection, COVID-19 Trial in Saint Petersburg (Molnupiravir)
Recruiting
- Viral Infection
- COVID-19
- Molnupiravir
-
Saint Petersburg, Russian FederationLimited Liability Company "Research Center Eco-Safety"
Jun 6, 2022
TURN-COVID Biobank: The Dutch Cohort Study for Evaluation of Use
Recruiting
- COVID-19
- casirivimab with imdevimab
- +2 more
-
Amsterdam, Noord Holland, Netherlands
- +3 more
Jan 13, 2022
Coronavirus Disease (COVID-19) Trial in Worldwide (Molnupiravir, Placebo)
Completed
- Coronavirus Disease (COVID-19)
- Molnupiravir
- Placebo
-
Birmingham, Alabama
- +225 more
Dec 5, 2022